Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Cysts 1Long Qt Syndrome 3 1Infertility 1Endometriosis 1Endometrial Neoplasms 1

Interventions

Radiotherapy 213Cisplatin 180Cyclophosphamide 168Doxorubicin 135Paclitaxel 125Vincristine 124Filgrastim 121Etoposide 103Carboplatin 100Methotrexate 83Gemcitabine 82Docetaxel 78Cytarabine 78Gene Expression Profiling 74Fluorouracil 74Prednisone 71Granulocyte Colony-Stimulating Factor 66Dexamethasone 66Leucovorin 62Polymerase Chain Reaction 47Immunohistochemistry 46Microarray Analysis 40Daunorubicin 38Irinotecan 37Ifosfamide 37Temozolomide 35Cetuximab 33Amplified Fragment Length Polymorphism Analysis 33Peripheral Blood Stem Cell Transplantation 32Mercaptopurine 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × NETWORK × Danazol × Clear all
NCT01779232 2016-04-27

Danazol Treatment in Endometriosis Women Before IVF

Centre for Endocrinology and Reproductive Medicine, Italy

Phase 4 Completed
150 enrolled
Gynecologic

Long Qt Syndrome 3, Endometriosis, Infertility, Ovarian Cysts

NCT00003946 2013-06-10

Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer

GOG Foundation

Phase 2 Completed
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡